Target intelligence / Profile preview

Immunoglobulin heavy variable 3-42 (pseudogene) (IGHV3-42)

Target
IGHV3-42
Molecular classification
Other (Immunoglobulin variable region gene segment, Pseudogene)
01

Overview

Immunoglobulin heavy variable 3-42 (IGHV3-42) is a member of the large family of immunoglobulin heavy chain variable region gene segments that, when functional, encode the variable domain of the heavy chain in immunoglobulins (antibodies)[1][3][5]. However, IGHV3-42 is annotated as a pseudogene[1], meaning that it carries mutations or deletions that prevent it from producing a functional V region in immunoglobulin heavy chains. IGHV genes, in general, contribute to antibody diversity via V(D)J recombination in developing B cells, but pseudogenes like IGHV3-42 are not used in productive antibody rearrangements and do not result in a functional protein product[3][5]. Because IGHV3-42 (pseudogene) does not encode a working protein and is not involved directly in immune response or disease processes, it is not considered a therapeutic target, nor is it a biomarker, nor does it interact with drugs. Note: If a query for IGHV3-42 intended to refer to a specific functional variable gene (rather than a pseudogene), more information would be needed. The available scientific literature and authoritative resources (such as IMGT) treat "IGHV3-42" as a pseudogene and not a functional antibody-encoding gene[1][3]. Key point: IGHV3-42 is a non-functional immunoglobulin variable region pseudogene; it does not encode a functional antibody heavy chain segment and is not a direct therapeutic target[1].

Other names
IGHV3-42IGHV3423-42P
02

Mechanism of action

No known mechanism of action due to lack of direct function

03

Biological functions

No direct biological function (as a pseudogene)
04

Disease associations

No direct role in disease (as a pseudogene)

Beyond the preview

Go deeper on Immunoglobulin heavy variable 3-42 (pseudogene) (IGHV3-42).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy variable 3-42 (pseudogene) (IGHV3-42).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call